President Donald Trump’s new executive order on psychedelics is being sold as a compassionate breakthrough for Americans suffering from serious mental illness.
But for families living with schizophrenia, psychosis, and severe bipolar disorder, it looks like a dangerous gamble built on the same failed foundation that has already abandoned our sickest loved ones.
On April 18, 2026, Trump signed an order directing federal agencies to accelerate medical treatments for serious mental illness, including psychedelic-based therapies, and to reduce regulatory barriers that slow research and access.
The White House said this will fast-track “innovative methods” for treating depression, PTSD, addiction, and suicide risk.
Media coverage from Time Magazine, NPR, and others has largely echoed that enthusiasm.
There is even special interest in powerful drugs like ibogaine.
On the surface, it sounds bold and compassionate. But the order talks broadly about “serious mental illness” while skipping a crucial reality: people with psychosis-related
Continue reading
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!